secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001453687-25-000093
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics stockholders elect three Class III directors and approve say-on-pay at 2025 annual meeting
--------------------------------------------------------------------------------

- 84.31% of outstanding shares represented; each director nominee elected with votes for >19.2M.
- Non-binding advisory say-on-pay approved: 19.7M for, 157k against, 2.0M broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2025 approved: 21.8M for, 6k against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368725000093/0001453687-25-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368725000093/rnac-20250613.htm
  HTML page:      https://secwatch.observer/filing/0001453687-25-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer